Need Help?

The cellular state space of AML unveils novel NPM1 subtypes with distinct clinical outcomes and immune evasion properties

Acute myeloid leukemia (AML) is a genetically and cellularly heterogeneous disease. We characterized 120 AMLs using bulk genomic and transcriptomic analyses (WES, MP-WGS, RNA-seq), and single-cell RNA sequencing (scRNA-seq). Our results reveal an extensive cellular heterogeneity that distorts the bulk transcriptomic profiles. Notably, NPM1 mutated AML could be stratified into two novel, clinically relevant classes (NPM1class I and NPM1class II).

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000001574 NextSeq 500 98
EGAD50000001575 NextSeq 500 232
EGAD50000001576 NextSeq 500 120
EGAD50000001577 unspecified 72
Publications Citations
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.
Nat Cancer 6: 2025 1821-1838
0
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.
Nat Commun 16: 2025 10592
1